Durvalumab vs Lovastatin

## Durvalumab vs Lovastatin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Lovastatin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Lovastatin**: First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Lovastatin — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Lovastatin — C24H36O5.

**Molecular Weight**: Durvalumab — N/A; Lovastatin — 404.5390 g/mol.

**Type**: Durvalumab — Antibody; Lovastatin — Small molecule.